NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Tuesday that its second quarter revenues increased 51 percent year over year.

Shares in NanoString fell in Wednesday morning trade, however, on concerns about reimbursement for its Prosigna test.

The Seattle-based molecular diagnostics firm brought in total revenues of $10.9 million for the three months ended June 30, up from $7.2 million in the second quarter of 2013. It beat the average Wall Street estimate of $10.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.